Skip to content
Screener

Total Equity at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$31.71B+5.9%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
$166.41M-32.4%
KLR
Kalaris TherapeuticsKLRS
$68.56M+7.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$451.84M-3.8%
HRO
HarrowHROW
$28.71M-49.1%
PVL
Palvella TherapeuticsPVLA
$232.31M+318%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized;none issued
Common stock, $0.0001 par value – 490,000,000 shares authorized; 62,155,685 and 61,758,454 shares issued and outstanding, respectively66
Additional paid-in capital1,728,9581,716,082
Accumulated deficit(1,616,863)(1,558,705)
Total stockholders’ equity112,101157,383
Total liabilities and stockholders’ equity$306,006$351,533

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's total equity?
Kodiak Sciences Inc (KOD) reported total equity of $112.1M in Q1 2026.
How has Kodiak Sciences Inc's total equity changed year-over-year?
Kodiak Sciences Inc's total equity increased by 3.0% year-over-year, from $108.84M to $112.1M.
What is the long-term trend for Kodiak Sciences Inc's total equity?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's total equity has grown at a -28.8% compound annual growth rate (CAGR), from $860.75M to $157.38M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Kodiak Sciences Inc's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude